# Electra Therapeutics

> Clinical-stage biotechnology company in South San Francisco, California, developing first-in-class antibody therapies against signal regulatory proteins (SIRP) for immunological diseases and cancer. Lead candidate ELA026 (ipsoprubart) targets SIRP-alpha/beta1/gamma to deplete the pathological myeloid cells and T lymphocytes that drive secondary hemophagocytic lymphohistiocytosis (sHLH), and is in the pivotal SURPASS Phase 2/3 study. A second program, ELA822, targets activated T lymphocytes for immunology and inflammation.

This file is generated by API Evangelist from the public profile at
https://github.com/api-evangelist/electra-therapeutics — Electra Therapeutics does not
publish an llms.txt of its own.

## APIs

Electra Therapeutics publishes no public API, developer portal, API documentation,
SDK, or machine-readable API contract (OpenAPI, AsyncAPI, GraphQL, MCP, A2A) as of
2026-08-04. Probes of the corporate host for /openapi.json, /openapi.yaml,
/swagger.json, /api-docs, /graphql, /llms.txt and every /.well-known/ discovery
path returned HTTP 404.

## Company

- [Website](https://electra-therapeutics.com/): Corporate site
- [Pipeline](https://electra-therapeutics.com/pipeline/): Development programs
- [Ipsoprubart (ELA026)](https://electra-therapeutics.com/ipsoprubart/): Lead candidate
- [Clinical Trials](https://electra-therapeutics.com/clinical-trials/): Trial information
- [Publications](https://electra-therapeutics.com/publications/): Peer-reviewed research
- [Leadership](https://electra-therapeutics.com/leadership/): Team
- [News](https://electra-therapeutics.com/news/): Press releases and announcements
- [Careers](https://electra-therapeutics.com/career-opportunities/): Open roles
- [Contact](https://electra-therapeutics.com/contact/): info@electra-therapeutics.com

## Policies

- [Privacy Policy](https://electra-therapeutics.com/privacy-policy/)
- [Terms of Use](https://electra-therapeutics.com/terms-of-use/)
- [Expanded Access Policy](https://electra-therapeutics.com/expanded-access-policy/)

## Artifacts

- [apis.yml](https://raw.githubusercontent.com/api-evangelist/electra-therapeutics/refs/heads/main/apis.yml): APIs.json 0.20 profile
- [Domain security](https://raw.githubusercontent.com/api-evangelist/electra-therapeutics/refs/heads/main/security/electra-therapeutics-domain-security.yml): TLS/DNS/email-auth probe
- [Well-known probe](https://raw.githubusercontent.com/api-evangelist/electra-therapeutics/refs/heads/main/well-known/electra-therapeutics-well-known.yml): /.well-known/ discovery probe results